Federal contract award
75N93020C00001
THE PURPOSE OF THE THIS CONTRACT IS TO PROVIDE A COMPREHENSIVE AND UNIFORM APPROACH TO EVALUATE INITIAL AND ON-GOING LABORATORY CAPABILITY AND READINESS TO CARRY OUT NIAID-FUNDED CLINICAL TRIAL PROTOCOLS (PROTOCOLS) BY (1) MONITORING COMPLIANCE WITH
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN81 — AIDS RESEARCH - BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $21.6M |
| Current contract value | $21.6M |
| Potential contract value / ceiling | $27.7M |
| Start date | Nov 15, 2019 |
| Current end date | Nov 14, 2026 |
| Potential end date | Nov 14, 2026 |
| Latest award activity | Nov 25, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 14 of 14 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Nov 25, 2025 | P00013 | $3.4M | PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE) |
| Nov 14, 2025 | P00012 | $0 | PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE) |
| May 28, 2025 | P00011 | $-589.5K | PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE) |
| Nov 12, 2024 | P00010 | $3.3M | PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE) |
| Nov 13, 2023 | P00009 | $3.2M | PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE) |
| Nov 3, 2022 | P00008 | $3.2M | PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE) |
| Feb 24, 2022 | P00007 | $0 | THE PURPOSE OF THE THIS CONTRACT IS TO PROVIDE A COMPREHENSIVE AND UNIFORM APPROACH TO EVALUATE INITIAL AND ON-GOING LABORATORY CAPABILITY AND READINESS TO CARRY OUT NIAID-FUNDED CLINICAL TRIAL PROTOCOLS (PROTOCOLS) BY (1) MONITORING COMPLIANCE WITH |
| Nov 2, 2021 | P00006 | $3.1M | THE PURPOSE OF THE THIS CONTRACT IS TO PROVIDE A COMPREHENSIVE AND UNIFORM APPROACH TO EVALUATE INITIAL AND ON-GOING LABORATORY CAPABILITY AND READINESS TO CARRY OUT NIAID-FUNDED CLINICAL TRIAL PROTOCOLS (PROTOCOLS) BY (1) MONITORING COMPLIANCE WITH |
| Oct 15, 2021 | P00005 | $0 | EO14042 THE PURPOSE OF THE THIS CONTRACT IS TO PROVIDE A COMPREHENSIVE AND UNIFORM APPROACH TO EVALUATE INITIAL AND ON-GOING LABORATORY CAPABILITY AND READINESS TO CARRY OUT NIAID-FUNDED CLINICAL TRIAL PROTOCOLS (PROTOCOLS) BY (1) MONITORING |
| Mar 23, 2021 | P00004 | $3.1M | THE PURPOSE OF THE THIS CONTRACT IS TO PROVIDE A COMPREHENSIVE AND UNIFORM APPROACH TO EVALUATE INITIAL AND ON-GOING LABORATORY CAPABILITY AND READINESS TO CARRY OUT NIAID-FUNDED CLINICAL TRIAL PROTOCOLS (PROTOCOLS) BY (1) MONITORING COMPLIANCE WITH |
| Mar 4, 2021 | P00003 | $0 | THE PURPOSE OF THE THIS CONTRACT IS TO PROVIDE A COMPREHENSIVE AND UNIFORM APPROACH TO EVALUATE INITIAL AND ON-GOING LABORATORY CAPABILITY AND READINESS TO CARRY OUT NIAID-FUNDED CLINICAL TRIAL PROTOCOLS (PROTOCOLS) BY (1) MONITORING COMPLIANCE WITH |
| Feb 11, 2021 | P00002 | $0 | THE PURPOSE OF THE THIS CONTRACT IS TO PROVIDE A COMPREHENSIVE AND UNIFORM APPROACH TO EVALUATE INITIAL AND ON-GOING LABORATORY CAPABILITY AND READINESS TO CARRY OUT NIAID-FUNDED CLINICAL TRIAL PROTOCOLS (PROTOCOLS) BY (1) MONITORING COMPLIANCE WITH |
| Jan 13, 2021 | P00001 | $0 | THE PURPOSE OF THE THIS CONTRACT IS TO PROVIDE A COMPREHENSIVE AND UNIFORM APPROACH TO EVALUATE INITIAL AND ON-GOING LABORATORY CAPABILITY AND READINESS TO CARRY OUT NIAID-FUNDED CLINICAL TRIAL PROTOCOLS (PROTOCOLS) BY (1) MONITORING COMPLIANCE WITH |
| Nov 7, 2019 | 0 | $3.0M | THE PURPOSE OF THE THIS CONTRACT IS TO PROVIDE A COMPREHENSIVE AND UNIFORM APPROACH TO EVALUATE INITIAL AND ON-GOING LABORATORY CAPABILITY AND READINESS TO CARRY OUT NIAID-FUNDED CLINICAL TRIAL PROTOCOLS (PROTOCOLS) BY (1) MONITORING COMPLIANCE WITH |
Estimated positioning window
Nov 1, 2026 – Jan 30, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2026-11-14 (13 days from calculation)
- +35 points
- 28 historical awards in this buyer and category group
- +15 points
- 14 recorded award transactions
- +10 points
- Latest award action: 2025-11-25
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.